PRELIMINARY RESULTS OF ASTX660, A NOVEL NON‐PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA. (12th June 2019) - Samaniego, F.; Hollebecque, A.; Foss, F.; Lister, J.; Mita, M.; Wagner‐Johnston, N.; Dyer, M.; You, B.; Prica, A.; Hernandez‐Llizaliturri, F.; Ferraldeschi, R.; Chan, D.; et al.